- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
BioAtla bids hello to public markets
Pfizer Ventures-backed cancer drug developer BioAtla's shares popped on its first day of trading yesterday following a $189m initial public offering.
Dec 17, 2020Workit wires in $12m
Blue Venture Fund returned as part of the latest funding to be raised by the mobile substance abuse treatment service.
Dec 17, 2020ZeroAvia takes off with series A funds
Amazon Climate Pledge Fund and Shell Ventures both participated in a $21.4m round that will support development of ZeroAvia's hydrogen aircraft powertrain.
Dec 17, 2020Plum plumps for series B2 funding
The Recruit-backed second-hand luxury goods marketplace had added an eight-figure dollar amount to the $20m it raised last year.
Dec 17, 2020Lydia lifts series B round to $131m
The Tencent and CNP Assurances-backed round has been boosted by $86m and the banking app developer has now pulled in over $160m in total.
Dec 17, 2020Exo Therapeutics executes $25m series A
The exosite drug developer has launched publicly to advance research from Harvard University and Salk Institute for Biological Studies.
Dec 17, 2020GoDaddy makes $365m Poynt acquisition
NAB, US Bancorp and Alphabet are set to exit payment processing technology provider Poynt in an acquisition sized at up to $365m.
Dec 17, 2020Nference nails $60m series C
Mayo Clinic had invested in and partnered the medical data software provider before joining a series C round also featuring NTTVC.
Dec 17, 2020Bioeconomy fund bags $213m second close
The European Commission-backed venture fund has secured commitments from Nestlé, Volkswohl Bund Versicherungen and Neste for its second close.
Dec 17, 2020Wolters Kluwer to put eOriginal on its books
Intel will exit the digital loan documentation software publisher in a $279m all-cash acquisition by Wolters Kluwer.
Dec 17, 2020Bestow gets $70m in series C round
Returning investor Sammons Financial contributed to a round that more than doubled the online life insurer's total funding to $145m.
Dec 17, 2020Exo Therapeutics executes $25m series A
Novartis Venture Fund is among the participants in a series A round disclosed by the exosite drug developer at its public launch.
Dec 17, 2020Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
